Since the causative agent of SARS, SARS‐CoV‐1, also binds to human ACE2 for cellular entry, we next assessed whether ACE2‐(G4S)6‐Fc could trap SARS‐CoV‐1 VLPs in human AM, and again found ACE2‐(G4S)6‐Fc mediated potent trapping of SARS‐CoV‐1 VLPs in human AM (Figure S2). The gene discussed is ACE2; the disease is severe acute respiratory syndrome.